Cheever MA - Search Results

1

Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine.

Disis ML, Grabstein KH, Sleath PR, Cheever MA. Disis ML, et al. Among authors: cheever ma. Clin Cancer Res. 1999 Jun;5(6):1289-97. Clin Cancer Res. 1999. PMID: 10389911 Clinical Trial.

2

Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity.

Knutson KL, Schiffman K, Cheever MA, Disis ML. Knutson KL, et al. Among authors: cheever ma. Clin Cancer Res. 2002 May;8(5):1014-8. Clin Cancer Res. 2002. PMID: 12006513 Clinical Trial.

3

Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines.

Disis ML, Gooley TA, Rinn K, Davis D, Piepkorn M, Cheever MA, Knutson KL, Schiffman K. Disis ML, et al. Among authors: cheever ma. J Clin Oncol. 2002 Jun 1;20(11):2624-32. doi: 10.1200/JCO.2002.06.171. J Clin Oncol. 2002. PMID: 12039923 Clinical Trial.

4

Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer.

Murray JL, Gillogly ME, Przepiorka D, Brewer H, Ibrahim NK, Booser DJ, Hortobagyi GN, Kudelka AP, Grabstein KH, Cheever MA, Ioannides CG. Murray JL, et al. Among authors: cheever ma. Clin Cancer Res. 2002 Nov;8(11):3407-18. Clin Cancer Res. 2002. PMID: 12429628

5

Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine.

Disis ML, Schiffman K, Guthrie K, Salazar LG, Knutson KL, Goodell V, dela Rosa C, Cheever MA. Disis ML, et al. Among authors: cheever ma. J Clin Oncol. 2004 May 15;22(10):1916-25. doi: 10.1200/JCO.2004.09.005. J Clin Oncol. 2004. PMID: 15143085 Clinical Trial.

6

In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene protein.

Disis ML, Smith JW, Murphy AE, Chen W, Cheever MA. Disis ML, et al. Among authors: cheever ma. Cancer Res. 1994 Feb 15;54(4):1071-6. Cancer Res. 1994. PMID: 7508819

7

Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.

Bernhard H, Disis ML, Heimfeld S, Hand S, Gralow JR, Cheever MA. Bernhard H, et al. Among authors: cheever ma. Cancer Res. 1995 Mar 1;55(5):1099-104. Cancer Res. 1995. PMID: 7532543

8

Immunity to the HER-2/neu oncogenic protein.

Disis ML, Bernhard H, Gralow JR, Hand SL, Emery SR, Calenoff E, Cheever MA. Disis ML, et al. Among authors: cheever ma. Ciba Found Symp. 1994;187:198-207; discussion 207-11. doi: 10.1002/9780470514672.ch13. Ciba Found Symp. 1994. PMID: 7540970 Review.

9

CD4+ T-cell immunity to mutated ras protein in pancreatic and colon cancer patients.

Qin H, Chen W, Takahashi M, Disis ML, Byrd DR, McCahill L, Bertram KA, Fenton RG, Peace DJ, Cheever MA. Qin H, et al. Among authors: cheever ma. Cancer Res. 1995 Jul 15;55(14):2984-7. Cancer Res. 1995. PMID: 7606715

10

T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl.

Cheever MA, Chen W, Disis ML, Takahashi M, Peace DJ. Cheever MA, et al. Ann N Y Acad Sci. 1993 Aug 12;690:101-12. doi: 10.1111/j.1749-6632.1993.tb44000.x. Ann N Y Acad Sci. 1993. PMID: 8103658 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters